Surrozen Inc.
April 01, 2024 - by Joey Ramson
$SRZN is the biggest loser in the Prism MarketView Public Health index today after the company announced an up to $192.5 million private placement. The funds will be used to expand its current Phase 1b trial in severe alcohol-associated hepatitis.
